Real world implementation of non-endoscopic triage testing for Barrett's oesophagus during COVID-19
Description
CONCLUSIONS: Cytosponge-biomarker tests enabled targeting of endoscopy services to higher-risk individuals, whereas those with TFF3 negative ultra-short segments could be reconsidered regarding their Barrett's oesophagus status and surveillance
